United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

US · SEC FORM 4

CV Sciences, Inc.

CVSI · OTC · CIK 0001510964 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

42.1 / 100

1 buyers · 10 purchase transaction lines · $114.8K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow

Purchase sizeLow

RoleModerate

RecencyLow

ConvictionStrong

Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35

Purchase size+8.1 / 25

Role+14.0 / 20

Recency+3.0 / 10

Conviction+10.0 / 10

What is holding the score back?

⚠ Cluster breadth is moderate · 1 insider(s), not 4+
⚠ Purchase size is modest relative to the model scale
⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct

CHEEVER CHARLIE E IIITenPercentOwner

●●●●●●●●●●

● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS1

PURCHASE CONCENTRATION100%Largest buyer: CHEEVER CHARLIE E III · $114.8K

CLUSTER BUYING · 15D1 insiderPeak activity: 2026-07-16–2026-07-31

Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

42.1 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot

Oct 1342.5
Oct 1442.3
Oct 1542.3
Oct 1642.2
Oct 1842.1

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

10Purchases

0Sales

0Other Form 4 lines

1SEC filings · 365 days

BUYING10 qualifying P line(s) · 180 days

SELLING0 sale line(s) · context only

OTHER0 exercise / withholding / award / gift / other lines

10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M: -50.0%
3M: -50.0%
6M: -75.0%
12M: -75.0%

Volatility & liquidity

Volatility: 227.8%
Beta: —
Avg daily value: USD 5,553

Valuation

Market cap: USD 2.3M
P/E: —

Fundamentals

Profit margin: -6.9%
ROE: -65.3%
Industry: Drug Manufacturers—Specialty & Generic

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-11 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short: 14,190
Previous report: 6,360
Avg daily volume: 1,839,462
Days to cover: ≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction date	Reporting owner	Type	Security	Shares	Avg. price	Approx. value	Source
2026-08-07	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	94,854	USD 0.02	USD 1,897	SEC filing ↗
2026-08-04	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	108,000	USD 0.02	USD 2,160	SEC filing ↗
2026-07-31	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	1,730,000	USD 0.02	USD 34,600	SEC filing ↗
2026-07-29	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	60,000	USD 0.02	USD 1,200	SEC filing ↗
2026-07-28	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	1,830,000	USD 0.02	USD 36,600	SEC filing ↗
2026-07-24	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	470,075	USD 0.02	USD 9,402	SEC filing ↗
2026-07-22	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	272,500	USD 0.02	USD 5,450	SEC filing ↗
2026-07-21	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	335,000	USD 0.02	USD 6,700	SEC filing ↗
2026-07-17	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	749,000	USD 0.02	USD 14,980	SEC filing ↗
2026-07-16	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	91,387	USD 0.02	USD 1,828	SEC filing ↗
2021-05-21	MAROON JOSEPH C MD	Purchase (P)	Common Stock	50,000	USD 0.38	USD 19,000	SEC filing ↗
2020-05-14	BLAKE PAUL	Purchase (P)	Common Stock	12,801	USD 0.39	USD 4,992	SEC filing ↗
2020-02-06	MAROON JOSEPH C MD	Purchase (P)	Common Stock	26,000	USD 0.94	USD 24,440	SEC filing ↗

Form 4 evidence

10 transaction lines in the latest 365-day window; 47 in local history.

Date	Owner	Type	Security	Shares	Avg. price	Approx. value	Source
2026-08-07	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	94,854	USD 0.02	USD 1,897	SEC filing ↗
2026-08-04	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	108,000	USD 0.02	USD 2,160	SEC filing ↗
2026-07-31	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	1,730,000	USD 0.02	USD 34,600	SEC filing ↗

Show recent Form 4 evidence (10 grouped rows)

Date	Owner	Type	Security	Shares	Avg. price	Approx. value	Source
2026-08-07	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	94,854	USD 0.02	USD 1,897	SEC filing ↗
2026-08-04	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	108,000	USD 0.02	USD 2,160	SEC filing ↗
2026-07-31	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	1,730,000	USD 0.02	USD 34,600	SEC filing ↗
2026-07-29	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	60,000	USD 0.02	USD 1,200	SEC filing ↗
2026-07-28	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	1,830,000	USD 0.02	USD 36,600	SEC filing ↗
2026-07-24	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	470,075	USD 0.02	USD 9,402	SEC filing ↗
2026-07-22	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	272,500	USD 0.02	USD 5,450	SEC filing ↗
2026-07-21	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	335,000	USD 0.02	USD 6,700	SEC filing ↗
2026-07-17	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	749,000	USD 0.02	USD 14,980	SEC filing ↗
2026-07-16	CHEEVER CHARLIE E III	Purchase (P)	Common Stock, $0.0001 par value per share	91,387	USD 0.02	USD 1,828	SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date	2026-10-18
Ranking version	US-v1.2
Data quality	PASS ELIGIBLE · —
Ticker	CVSI
CIK	0001510964
Sector	Healthcare
Industry	Drug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC	2834 Pharmaceutical Preparations
Exchange	OTC

Data coverage

Local Form 4 history	47 transaction lines from 2020-01-07 to 2026-08-07 13 P purchase lines · 34 S sale lines · 0 other lines
SEC company submissions	Open SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.